Meyer Handelman Co. Has $821,000 Stock Holdings in Solventum Co. (NYSE:SOLV)

Meyer Handelman Co. reduced its position in Solventum Co. (NYSE:SOLV) by 46.2% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 12,422 shares of the company’s stock after selling 10,662 shares during the period. Meyer Handelman Co.’s holdings in Solventum were worth $821,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Copeland Capital Management LLC acquired a new stake in shares of Solventum in the third quarter valued at approximately $26,000. Modus Advisors LLC bought a new stake in Solventum in the 4th quarter valued at $25,000. Mather Group LLC. acquired a new stake in Solventum during the 3rd quarter valued at $27,000. Hollencrest Capital Management acquired a new stake in Solventum during the 2nd quarter valued at $25,000. Finally, True Wealth Design LLC boosted its position in Solventum by 23,550.0% during the third quarter. True Wealth Design LLC now owns 473 shares of the company’s stock worth $33,000 after purchasing an additional 471 shares during the period.

Wall Street Analysts Forecast Growth

SOLV has been the topic of several research analyst reports. Morgan Stanley increased their price objective on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research report on Monday, November 11th. Mizuho began coverage on shares of Solventum in a research report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price objective for the company. Piper Sandler boosted their price objective on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. Wolfe Research started coverage on Solventum in a research note on Thursday, September 26th. They set a “peer perform” rating on the stock. Finally, Stifel Nicolaus assumed coverage on Solventum in a research note on Tuesday, October 8th. They issued a “buy” rating and a $82.00 price target for the company. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat, Solventum has an average rating of “Hold” and a consensus price target of $68.29.

Solventum Stock Performance

Solventum stock opened at $70.25 on Wednesday. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15. The stock’s fifty day moving average price is $69.18 and its two-hundred day moving average price is $65.24. Solventum Co. has a one year low of $47.16 and a one year high of $96.05.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.